98%
921
2 minutes
20
Background: The serotonin 5-HT receptor has attracted much more research attention, due to the therapeutic potential of its ligands being increasingly recognized, and the possibilities that lie ahead of these findings. There is a growing body of evidence indicating that these ligands have procognitive, pro-social, and anti-depressant properties, which offers new avenues for the development of treatments that could address socially important conditions related to the malfunctioning of the central nervous system. The aim of our study was to unravel the molecular determinants for 5-HTR ligands that govern their activity towards the receptor.
Methods: In response to the need for identification of molecular determinants for 5-HTR activity, we prepared a comprehensive collection of 5-HTR ligands, carefully gathering literature and patent data. Leveraging molecular modeling techniques, such as pharmacophore hypothesis development, docking, and molecular dynamics simulations enables to gain valuable insights into the specific interactions of 5-HTR ligand groups with the receptor.
Results: The obtained comprehensive set of 2160 compounds was divided into dozens of subsets, and a pharmacophore model was developed for each group. The results from the docking and molecular dynamics simulations have enabled the identification of crucial ligand-protein interactions that are essential for the compound's activity towards 5-HTR.
Conclusions: The findings from the molecular modeling study provide valuable insights that can guide medicinal chemists in the development of new 5-HTR ligands. Considering the pharmacological significance of these compounds, they have the potential to become impactful treatments for individuals and communities in the future. Understanding how different crystal/cryo-EM structures of 5-HTR affect molecular modeling experiments could have major implications for future computational studies on this receptor.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11387456 | PMC |
http://dx.doi.org/10.1007/s43440-024-00622-4 | DOI Listing |
Sci Adv
April 2024
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Serotonin [5-hydroxytryptamine (5-HT)] acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HTR have confirmed roles in native tissue and are validated drug targets. Despite 5-HTR's therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive.
View Article and Find Full Text PDFbioRxiv
October 2023
Department of Neuroscience, Icahn School of Medicine at Mount Sinai; New York, New York 10029.
Serotonin (5-hydroxytryptamine, 5-HT) acts via 13 different receptors in humans. Of these receptor subtypes, all but 5-HTR have confirmed roles in native tissue and are validated drug targets. Despite 5-HTR's therapeutic potential and plausible druggability, the mechanisms of its activation remain elusive.
View Article and Find Full Text PDFJ Physiol
December 2023
Department of Anatomy & Physiology, University of Melbourne, Melbourne, VIC, Australia.
Agonists of dopamine D2 receptors (D2R), 5-hydroxytryptamine (5-HT, serotonin) receptors (5-HTR) and ghrelin receptors (GHSR) activate neurons in the lumbosacral defecation centre, and act as 'colokinetics', leading to increased propulsive colonic motility, in vivo. In the present study, we investigated which neurons in the lumbosacral defecation centre express the receptors and whether dopamine, serotonin and ghrelin receptor agonists act on the same lumbosacral preganglionic neurons (PGNs). We used whole cell electrophysiology to record responses from neurons in the lumbosacral defecation centre, following colokinetic application, and investigated their expression profiles and the chemistries of their neural inputs.
View Article and Find Full Text PDFJ Comput Aided Mol Des
July 2023
Department of Pharmaceutical Chemistry, Philipps-University Marburg, Marbacher Weg 8, 35032, Marburg, Germany.
Computer-aided approaches to ligand design need to balance accuracy with speed. This is particularly true for one of the key parameters to be optimized during ligand development, the free energy of binding (G). Here, we developed simple models based on the Linear Interaction Energy approximation to free energy calculation for a G protein-coupled receptor, the serotonin receptor 2A, and critically evaluated their accuracy.
View Article and Find Full Text PDFMetab Brain Dis
December 2022
Department of Anesthesiology, the First People's Hospital of Jiangxia District, Wuhan, China.
Kaixinsan powder (KXS), a classic prescription of traditional Chinese Medicine (TCM), is widely used in the treatment of depression, but its mechanism remains unclear. The network pharmacology method was used to constructe the "herb-component-target" network, and elucidated KXS potential mechanisms of action in the treatment of depression. Moreover, molecular docking was applied to valid the important interactions between the ingredients and the target protein.
View Article and Find Full Text PDF